Skip to content

A research study looking at how the compound NNC0194-0499 works with birth control pills in women not able to bear children.

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-503595-24-00
Acronym
NN9500-4619
Enrollment
30
Registered
2023-07-17
Start date
2023-12-14
Completion date
2024-12-30
Last updated
2024-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers (Non-alcoholic steatohepatitis (NASH))

Interventions

None listed

Sponsors

Novo Nordisk A/S
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Austria

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026